Young Li
Stock Analyst at Jefferies
(0.22)
# 4,307
Out of 4,981 analysts
6
Total ratings
33.33%
Success rate
-31.06%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Hold | $24 → $9 | $9.31 | -3.33% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $66.68 | +72.47% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.42 | -11.97% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $31.72 | +89.16% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $8.67 | +430.57% | 1 | Jul 16, 2021 |
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $9.31
Upside: -3.33%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $66.68
Upside: +72.47%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.42
Upside: -11.97%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $31.72
Upside: +89.16%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $8.67
Upside: +430.57%